|
Napp Pharmaceutical ousts best-of-breed
|
31/08/2006
|
| |
|
The argument over monolithic versus best-of-breed IT has raged for years, but the pharmaceutical sector has real experience – and doesn’t like the latter. Brian Tinham talks to Napp’s business projects head, Chris Jones, about why and what he's doing about it
|
| |
Author
Brian Tinham
|
| |
| |
|
This material is protected by Findlay Publications copyright 2008.
See Terms and Conditions.
One-off usage is permitted but bulk copying is not.
For multiple copies contact the sales team.
|
| Email this article |
| |
|
|